Figure 2 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Figure 2 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

<p>NKCEs enhance NK-cell activity against MHH-CALL-4 cell line. CD107a expression and IFNγ production by resting NK cells from healthy donors (<i>n</i> = 3–6) cocultured for 6 hours with MHH-CALL-4 cells in the absence or presence of CD19-NKCEs, CD20-NKCEs, or the control molecules...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Natalia Colomar-Carando (14611340) (author)
Andere auteurs:	Laurent Gauthier (15129623) (author), Pietro Merli (15129626) (author), Fabrizio Loiacono (5306981) (author), Paolo Canevali (332990) (author), Michela Falco (368897) (author), Federica Galaverna (8825531) (author), Benjamin Rossi (15129629) (author), Frédéric Bosco (15129632) (author), Mélody Caratini (15129635) (author), Maria Cristina Mingari (8409327) (author), Franco Locatelli (15127797) (author), Eric Vivier (48284) (author), Raffaella Meazza (7179467) (author), Daniela Pende (15129638) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Immuno-oncology Hematological Cancers Leukemias Immunology NK cells Immunotherapy Stem cell transplantation
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Figure 1 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
door: Natalia Colomar-Carando (14611340)
Gepubliceerd in: (2025)

Figure 3 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
door: Natalia Colomar-Carando (14611340)
Gepubliceerd in: (2025)

Figure 4 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
door: Natalia Colomar-Carando (14611340)
Gepubliceerd in: (2025)

Figure 5 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
door: Natalia Colomar-Carando (14611340)
Gepubliceerd in: (2025)

Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
door: Amir T. Fathi (15313195)
Gepubliceerd in: (2025)

Supplemental Figure 2 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
door: Amir T. Fathi (15313195)
Gepubliceerd in: (2025)

Investigation on the Occurrence of Premature Ovarian Insufficiency after Allogeneic Haematopoietic Stem Cell Transplantation and Prognosis Analysis - a single-center real-world cross-sectional study
door: 辰宇石 (22420348)
Gepubliceerd in: (2025)

Reducing Anxiety and Improving Adherence in Kidney Transplant Recipients: A Cognitive Behavioral Intervention -Based Approach
door: Chao Zhong (22679885)
Gepubliceerd in: (2025)

<b>B lymphocytes impede Tregs to erode islet tolerance in Type 1 Diabetes</b>
door: Christopher S. Wilson (22462794)
Gepubliceerd in: (2025)

Supplementary Figure 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
door: Wei Liu (20030)
Gepubliceerd in: (2025)

Supplementary Figure 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
door: Wei Liu (20030)
Gepubliceerd in: (2025)

Supplementary Figure 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
door: Wei Liu (20030)
Gepubliceerd in: (2025)

Supplementary Figure 4 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
door: Wei Liu (20030)
Gepubliceerd in: (2025)

Supplementary Figure 5 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
door: Wei Liu (20030)
Gepubliceerd in: (2025)

Supplementary Figure 6 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
door: Wei Liu (20030)
Gepubliceerd in: (2025)

Supplementary Figure7 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
door: Wei Liu (20030)
Gepubliceerd in: (2025)

Supplementary Table 1 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
door: Wei Liu (20030)
Gepubliceerd in: (2025)

Supplementary Table 2 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
door: Wei Liu (20030)
Gepubliceerd in: (2025)

Supplementary Table 3 from BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
door: Wei Liu (20030)
Gepubliceerd in: (2025)

Data Sheet 1_Glycocalyx kinetics and injury during liver procurement and transplantation as predictors of early graft dysfunction.docx
door: Nassiba Beghdadi (9577919)
Gepubliceerd in: (2025)

Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i>-Mutant Clonal Hematopoiesis
door: Rathana Kim (15135915)
Gepubliceerd in: (2025)

Pearson correlations between willingness to participate in engagement and past participation in engagement.
door: Becca Beets (12878526)
Gepubliceerd in: (2025)

Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
door: Sushil Kumar (20371917)
Gepubliceerd in: (2025)

Cerebellar Purkinje cell (PC)-specific amyloid precursor protein (APP) expression modulates motor function.
door: Miao-Jin Ji (22676552)
Gepubliceerd in: (2025)

A Guide to Creative Engagement in Public Spaces
door: Victoria Foster (21491630)
Gepubliceerd in: (2025)

Reliability for the five sub-dimensions of past participation in engagement.
door: Becca Beets (12878526)
Gepubliceerd in: (2025)

Descriptive statistics for five sub-dimensions of engagement activities.
door: Becca Beets (12878526)
Gepubliceerd in: (2025)

Core Nature restoration
door: Fedorchenko (22513145)
Gepubliceerd in: (2025)

Results of reliability tests for the five sub-dimensions of engagement activities.
door: Becca Beets (12878526)
Gepubliceerd in: (2025)

Blog: Engaging with digital platforms for fundraising – a view from Montenegro
door: Milana Čergić (22674940)
Gepubliceerd in: (2025)

Exogenous amyloid precursor protein (APP) expression restored the defects of the sIPSCs evoked by Nav1.6-mediated Purkenji cell inputs in APP-null mice.
door: Miao-Jin Ji (22676552)
Gepubliceerd in: (2025)

Comparison of hierarchical classifier performance among four machine learning models for the early-loss, intermediate-loss, and late/no-loss groups.
door: Raiki Yoshimura (22676573)
Gepubliceerd in: (2025)

Comparison of multi-class classifier performance among four machine learning models for early-loss, intermediate-loss, and late/no-loss groups.
door: Raiki Yoshimura (22676573)
Gepubliceerd in: (2025)

Comparison of binary classifier performance among four machine learning models for early-loss, intermediate-loss, and late/no-loss groups.
door: Raiki Yoshimura (22676573)
Gepubliceerd in: (2025)

Comparison of performance of four machine learning models for long-term graft loss prediction.
door: Raiki Yoshimura (22676573)
Gepubliceerd in: (2025)

Comparison of prediction performance with previously reported metrics.
door: Raiki Yoshimura (22676573)
Gepubliceerd in: (2025)

Comparison of performance of four machine learning models for early graft loss prediction.
door: Raiki Yoshimura (22676573)
Gepubliceerd in: (2025)

Predicting stratified groups in the validation cohort: (A) Workflows for the multi-class classification and hierarchical classification models are illustrated.
door: Raiki Yoshimura (22676573)
Gepubliceerd in: (2025)

Stratification and characterization of groups showing different graft survival: (A) UMAP visualization of the stratified derivation cohort data based on the distance matrix from the RF clustering.
door: Raiki Yoshimura (22676573)
Gepubliceerd in: (2025)

Prediction of early graft loss at the individual level and identification of crucial factors: (A) Survival curves for all patients who experienced graft loss are plotted.
door: Raiki Yoshimura (22676573)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_g0jmkf7ucg8dtda8id8gfef530